Medici Capital Partners

Richard Yen, the firm's founder, is the sole named investment principal. He brings over a decade of late-stage consumer tech investing experience from Saban Capital Group and an earlier career in quantitative finance and startup operations at D. E. Shaw & Co. The firm does not publicly list additional investment committee members or partners.

The firm cites its relationships at the intersection of Silicon Valley and Hollywood as a primary sourcing engine. Yen's operating background at D. E. Shaw's internet incubator and his tenure investing for media billionaire Haim Saban provide a network across technology, media, and digital consumer brands. The firm also executes secondary transactions directly with employees and shareholders seeking liquidity.

The firm's stated geographic focus is on North American consumer technology companies. It does support portfolio companies in international expansion, leveraging global relationships in product strategy and business development, but it does not advertise a dedicated ex-US investment mandate.

Medici has not publicly disclosed a formal co-investment policy. The firm participates in primary growth and pre-IPO rounds alongside other venture and growth-stage investors, as seen with its positions in companies that later went public, but it does not market a dedicated club-deal or co-investment vehicle for external allocators.

No philanthropic structure or separate foundation associated with Medici Capital Partners is disclosed in public records or on the firm's website.

The firm focuses on late-stage venture, growth equity, and pre-IPO financings for companies that have already achieved product-market fit and profitability. It also executes direct secondary transactions to purchase existing shareholder stakes in B2C technology companies.

Medici invests exclusively in consumer technology and does not pursue enterprise SaaS, deep tech, healthcare, or B2B infrastructure deals. Its stated sub-sectors are consumer internet, media and sports, and gaming, and the firm positions this B2C specialization as a deliberate contrast to generalist technology investors.